The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancerDevalingam Mahalingam, Steffan T. Nawrocki, Giovanni Selvaggi et al.|BMC Cancer|2015Cited by 19
Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple MyelomaKevin R. Kelly, Steffan T. Nawrocki, Kaijin Wu et al.|Blood|2016Cited by 9